In the last year, shares of dating site Match (MTCH) marched higher while Bumble (BMBL) faltered. Bears hold a 10.59% short interest in Bumble stock.
On Monday, the stock gained nearly 50%. The WSJ reported on Monday that Bumble is negotiating a buyout deal with Ithaca Holdings. At $1 billion, the enterprise valuation offer would imply a market capitalization of up to $700 million. That would give the stock around 10% further upside.
Bristol-Myers (BMY) continued its steep stock decline. The stock closed at $57.58, erasing the June-September rally. Despite posting positive topline results for two Phase 3 trials, BMY stock fell from $60 to $57.58.
The ALOFT-IPF trial evaluated subjects with idiopathic pulmonary fibrosis (IPF). The study met its primary endpoint.
In a Phase 3 ACTION-1 trial, the drug met its primary endpoint for improving progression-free survival in patients with advanced gastroenteropancreatic neuroendocrine tumors who had progressed following lutetium-177-based therapy.
Fair Issac (FICO) jumped by nearly 11%. The stock bottomed at $586.05 on Sept. 29, when TransUnion (TRU) continued offering mortgage pricing for VantageScore 4.0 through December 2028 for just $0.99 per mortgage origination score.
Speculators are betting that the worst is behind FICO stock. Yet with no pricing power, the company’s long-term prospects appear weak.
